Verastem Inc. Stock
Price
Target price
€3.64
€3.64
-1.080%
-0.04
-1.080%
€19.95
31.05.24 / Tradegate
WKN: A3EHM3 / Symbol: VSTM / Name: Verastem / Stock / Biotechnology & Medical Research / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Verastem Inc. Stock
A loss of -1.080% shows a downward development for Verastem Inc..
Verastem Inc. is currently one of the favorites of our community with 13 Buy predictions and no Sell predictions.
With a target price of 19 € there is potential for a 421.98% increase which would mean more than doubling the current price of 3.64 € for Verastem Inc..
Our community identified positive and negative aspects for Verastem Inc. stock for the coming years. 6 users see the criterium "Worthwhile Investment for the next years" as a plus for the Verastem Inc. stock. On the other hand our users think that "General Risks" could be a problem in the future.
Pros and Cons of Verastem Inc. in the next few years
Pros
?
G***** c******* t* c**********
?
B****
?
M***** P*******
Cons
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Verastem Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Verastem Inc. | -1.080% | -3.191% | -57.674% | -67.748% | -51.788% | -90.712% | - |
| Ardelyx Inc. | 3.070% | 1.608% | 5.441% | 102.500% | 9.308% | 7.085% | - |
| Evolus Inc | - | 0.000% | 7.477% | 37.725% | 27.072% | 32.948% | - |
| Salarius Pharmaceuticals Inc. | - | -3.015% | -6.311% | -66.724% | -30.450% | -98.501% | -99.994% |
Comments
Verastem, Inc. (NASDAQ: VSTM) had its price target lowered by analysts at Alliance Global Partners from $34.00 to $20.00. They now have a "buy" rating on the stock.
Show more
Ratings data for VSTM provided by MarketBeat
Verastem, Inc. (NASDAQ: VSTM) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $17.50 price target on the stock.
Show more
Ratings data for VSTM provided by MarketBeat
Verastem, Inc. (NASDAQ: VSTM) had its price target lowered by analysts at Royal Bank of Canada from $32.00 to $16.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for VSTM provided by MarketBeat